[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

Kaviani et al., 2023 - Google Patents

Chiral resolution methods for racemic pharmaceuticals based on cocrystal formation

Kaviani et al., 2023

Document ID
18101676082486543741
Author
Kaviani R
Jouyban A
Shayanfar A
Publication year
Publication venue
CrystEngComm

External Links

Snippet

Currently, more than half of available drugs on the market are chiral, and approximately 90% of these drugs are marketed as racemates. When these racemic medications are exposed to the chiral environment of the human body, differences in their activity appear. The …
Continue reading at pubs.rsc.org (other versions)

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/06—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom containing only hydrogen and carbon atoms in addition to the ring nitrogen atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00—Indexing scheme relating to specific properties of organic compounds
    • C07B2200/13—Crystalline forms, e.g. polymorphs
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00—Indexing scheme relating to specific properties of organic compounds
    • C07B2200/07—Optical isomers
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D223/00—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B59/00—Introduction of isotopes of elements into organic compounds; Labelled organic compounds per se

Similar Documents

Publication Publication Date Title
Karimi-Jafari et al. Creating cocrystals: A review of pharmaceutical cocrystal preparation routes and applications
Chow et al. Simultaneously improving the mechanical properties, dissolution performance, and hygroscopicity of ibuprofen and flurbiprofen by cocrystallization with nicotinamide
Sekhon Pharmaceutical co-crystals-a review
Neurohr et al. Naproxen–nicotinamide cocrystals: Racemic and conglomerate structures generated by CO2 antisolvent crystallization
Maddileti et al. Soluble cocrystals of the xanthine oxidase inhibitor febuxostat
Kaviani et al. Chiral resolution methods for racemic pharmaceuticals based on cocrystal formation
Brandel et al. Impact of molecular flexibility on double polymorphism, solid solutions and chiral discrimination during crystallization of diprophylline enantiomers
Hossain Mithu et al. Advanced methodologies for pharmaceutical salt synthesis
Kumari et al. Enhancing the pharmaceutical properties of pirfenidone by mechanochemical cocrystallization
Yadav et al. COCRYSTALS: AN ALTERNATIVE APPROACH TO MODIFY PHYSICOCHEMICAL PROPERTIES OF DRUGS.
JP2009542787A (en) Short-acting benzodiazepine salts and their polymorphic forms
Charpentier et al. Comparing and quantifying the efficiency of cocrystal screening methods for praziquantel
Zhang et al. Hydrates and Solvates of Acotiamide Hydrochloride: Crystallization, Structure, Stability, and Solubility
CN102924434B (en) Dexrabeprazole sodium monohydrate crystal form and preparation method thereof
Varma et al. Designing of stable co-crystals of zoledronic acid using suitable coformers
Zhou et al. Co-crystal formation based on structural matching
Loya et al. Mechanochemistry as a tool for crystallizing inaccessible solids from viscous liquid components
Saikia et al. Role of Mechanochemistry in Solid form selection and identification of the drug praziquantel
Harfouche et al. Discovery of new proxyphylline-based chiral cocrystals: solid state landscape and dehydration mechanism
MacEachern et al. Transformation under pressure: Discovery of a novel crystalline form of anthelmintic drug Praziquantel using high-pressure supercritical carbon dioxide
Meanwell The emerging utility of co-crystals in drug discovery and development
Al-Dulaimi et al. Co-crystals for improving solubility and bioavailability of pharmaceutical products
Cappuccino et al. Co-crystalline solid solution affords a high-soluble and fast-absorbing form of praziquantel
Malik et al. A comprehensive insight on pharmaceutical co-crystals for improvement of aqueous solubility
Ueda et al. Baloxavir Marboxil shows anomalous conversion of crystal forms from stable to metastable through formation of specific solvate form